| Literature DB >> 20351956 |
Maha Ghanem1, Enace Abd Elaal, Mogedda Mehany, Kawthar Tolba.
Abstract
BACKGROUND: A key component in the management of chronic obstructive pulmonary disease (COPD) patients is pulmonary rehabilitation (PR), the corner stone of which is exercise training. AIM: This study aims to evaluate the effect of a two-months, home-based PR program with outpatient supervision every two weeks, on exercise tolerance and health-related quality of life (HRQL) using Arabic-translated standardized generic and specific questionnaires in COPD patients recently recovered from acute exacerbation,Entities:
Keywords: Chronic respiratory disease questionnaire - self - administered standardized format; pulmonary rehabilitation; quality of life
Year: 2010 PMID: 20351956 PMCID: PMC2841804 DOI: 10.4103/1817-1737.58955
Source DB: PubMed Journal: Ann Thorac Med ISSN: 1998-3557 Impact factor: 2.219
Socio-demographic and clinical data of participated COPD patients
| Item | Group 1 rehabilitation group N = 2 (%) | Group 2 usual care control group N = 14 (%) | Total N = 39 (%) | |
|---|---|---|---|---|
| Age (Mean±SD) | 56.96 ± 11.59 | 56.43 ± 9.03 | 0.88 | |
| Residence | ||||
| Urban | 11 (44.0) | 2 (14.3) | 13 (33.3) | 0.062 |
| Rural | 14 (56.0) | 12 (85.7) | 26 (66.7) | |
| Smoking | ||||
| Non smoker | 1 (4.0) | 1 (7.1) | 2 (5.1) | 0.37 |
| Mild (0-10 pack/year) | 6 (24.0) | 4 (28.6) | 10 (25.6) | 0.47 |
| Moderate (10-20 pack/year) | 11 (44.0) | 6 (42.9) | 17 (43.6) | 0.39 |
| Heavy (> 20 pack/year) | 7 (28.0) | 3 (21.4) | 10 (25.6) | 0.47 |
| Duration of illness (years) | ||||
| <10 | 10 (40) | 8 (57.1) | 18 (46.2) | 0.24 |
| 10-20 | 10 (40) | 4 (28.6) | 14 (35.9) | 0.36 |
| 20-25 | 5 (20) | 2 (14.3) | 7 (17.9) | 0.50 |
| Severity of disease | ||||
| Moderate | 22 (88) | 10 (71.4) | 32 (82) | 0.19 |
| Severe | 3 (12) | 4 (28.6) | 7 (18) | 0.19 |
| Grades of dyspnea at time of enrolment | ||||
| II | 1 (7.1) | 3 (12.0) | 4 (10.3) | 0.47 |
| III | 11 (78.6) | 22 (88.0) | 33 (84.5) | 0.38 |
| IV | 2 (14.3) | 0 (0) | 2 (5.1) | 0.18 |
| Amount of sputum | ||||
| Small | 5 (35.7) | 6 (24) | 11 (28.2) | 0.35 |
| Moderate | 5 (35.7) | 8 (32) | 13 (33.3) | 0.45 |
| Large | 4 (28.6) | 11 (44) | 15 (38.5) | 0.27 |
| Cor pulmonale | ||||
| No | 17 (68.0) | 8 (57.1) | 25 (64.1) | 0.37 |
| Compensated | 7 (28.0) | 5 (35.76) | 12 (30.8) | 0.44 |
| De-compensated | 1 (4) | 1 (7.1) | 2 (5.1) | 0.37 |
| Respiratory failure | ||||
| No | 8 (57.1) | 7 (28.0) | 15 (38.5) | 0.08 |
| Yes | 6 (42.9) | 18 (72. 0) | 24 (69.2) | |
| Maintenance therapy | ||||
| Oral bronchodilators | ||||
| No | 3 (12.0) | 0 (0) | 3 (7.7) | 0.23 |
| Yes | 22 (88.0) | 14 (100.0) | 36 (92.3) | |
| Inhaled bronchodilators | ||||
| No | 11 (44.4) | 3 (21.4) | 14 (35.9) | 0.14 |
| Yes | 14 (56.0) | 11 (78.6) | 25 (71.8) | |
| Oral corticosteroids | ||||
| No | 1 (4.0) | 0 (0) | 1 (2.6) | 0.38 |
| Yes | 24 (96.0) | 14 (100) | 38 (97.4) |
COPD = Chronic obstructive pulmonary disease
Baseline and two months medical outcomes study 36-items' short form MOS (SF-36) scales
| SF-36 scale | Group 1 (Rehabilitation group) N = 25 | Group 2 (Usual care control group) N = 14 | ||||
|---|---|---|---|---|---|---|
| Enroll | 2 months | Enroll | 2 months | |||
| Change in health | 46.00 ± 11.81 | 76.00 ± 8.78 | < 0.001 | 35.71 ± 6.16 | 33.53 ± 14.62 | 0.71 |
| Physical component | ||||||
| Physical function | 30.64 ± 10.45 | 75.08 ± 14.31 | < 0.001 | 25.86 ± 26.44 | 28.58 ± 27.51 | 0.79 |
| Role physical | 19.00 ± 29.12 | 64.00 ± 26.10 | < 0.001 | 5.43 ± 14.58 | 7.14 ± 18.16 | 0.79 |
| Pain | 37.20 ± 6.14 | 61.20 ± 11.30 | < 0.001 | 25.00 ± 9.41 | 28.01 ± 8.14 | 0.37 |
| General health | 46.00 ± 9.90 | 52.00 ± 9.68 | 0.04 | 36.43 ± 7.19 | 34.17 ± 6.12 | 0.38 |
| Mental component | ||||||
| Mental health (emotional well-being) | 47.36 ± 5.12 | 48.00 ± 5.66 | 0.68 | 39.14 ± 0.07 | 36.15 ± 4.17 | 0.31 |
| Social function | 50.72 ± 15.90 | 54.76 ± 13.12 | 0.33 | 44.93 ± 10.44 | 40.39 ± 4.34 | 0.15 |
| Role emotional | 3.96 ± 10.94 | 96.00 ± 20.00 | < 0.001 | 14.29 ± 36.31 | 13.27 ± 33.37 | 0.94 |
| Energy/fatigue (vitality) | 50.80 ± 9.65 | 79.60 ± 10.89 | < 0.05 | 46.79 ± 8.23 | 44.78 ± 7.33 | 0.50 |
Baseline and two months six minutes walk distance of the two studied groups of COPD patients
| Outcome measure | Group 1 (Rehabilitation group) N = 25 | Group 2 (Usual care control group) N = 14 | Mean differences between groups (95% CI) | |||
|---|---|---|---|---|---|---|
| Enroll | 2 months | Enroll | 2 months | |||
| Six minutes walk distance in meters | ||||||
| Mean ± SD | 88.79 ± 19.14 | 141.71 ± 23.11 | 83.79 ± 15.9 | 68.56 ± 32.11 | 58.15 ± 11.23 | < 0.001 |
| Chronic respiratory disease questionnaire | ||||||
| Dyspnea (range 5-35) | 11.8 ± 5.0 | 19.6 ± 5.2 | 12.4 ± 4.4 | 13.5 ± 4.3 | 5.5 (3.0-9.0) | 0.003 |
| Fatigue (range 4-28) | 9.8 ± 2.8 | 17.4 ± 5.4 | 11.6 ± 6.1 | 13.2 ± 5.1 | 5.3 (1.9-9.8) | 0.004 |
| Emotion (range 7-49) | 22.1 ± 5.8 | 33.5 ± 7.2 | 27.0 ± 12.6 | 29.7 ± 11.4 | 8.7 (2.5-15.0) | 0.008 |
| Short form 36 (range 0-100) | ||||||
| Physical component | 30.6 ± 14.2 | 56.3 ± 24.0 | 40.6 ± 21.9 | 47.2 ± 24.2 | 20.1 (3.3-36.8) | 0.02 |
| Mental component | 26.3 ± 14.6 | 39.0 ± 20.0 | 30.4 ± 19.9 | 32.4 ± 22.2 | 10.6 (-0.3-21.6) | 0.047 |
| Pulmonary function tests (spirometry) | ||||||
| FVC (L/min) | 1.37 ± 0.50 | 1.42 ± 0.59 | 1.09 ± 0.41 | 0.98 ± 0.20 | 0.44 (0.11-0.77) | 0.01 |
| FVC (% pred) | 36.24 ± 14.17 | 40.4 ± 16.16 | 29.0 ± 10.91 | 26.57 ± 7.13 | 13.83 (2.5-14.9) | 0.00 |
| FEV1 (L/min) | 0.80 ± 0.35 | 0.83 ± 0.52 | 0.62 ± 0.18 | 0.64 ± 0.20 | 0.19 (-0.1-0.48) | 0.2 |
| FEV1 (%pred) | 29.44 ± 13.14 | 29.92 ± 20.21 | 23.21 ± 7.70 | 23.14 ± 7.56 | 6.78 (-5.01-18.57) | 0.25 |
#Data expressed as mean score (SD);
Increased score denotes improvement; P < 0.05 between baseline and two months in rehabilitation group using paired t test;
P < 0.001 between group 1 and group 2 after two months of enrolment using unpaired t tests;
P < 0.01 between group 1 and 2 after two months of enrolment using unpaired t tests;
P < 0.05 enroll vs 2 months in group two using paired t tests;
P < 0.05 between group 1 and 2 after twomonths of enrolment using unpaired t tests;
P > 0.05 between group1 and 2 after two months of enrolment using unpaired t tests, COPD = Chronic obstructive pulmonary disease